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HIV is evolution gone mad and bad. The virus infects a person and rapidly 
diversifi  es to become a huge swarm of viruses, each equipped differently to 
resist the onslaught of diverse T cells and antibodies. We can’t expect to 
predict details of the struggle between virus and immunity, right? Wrong—
maybe we can make some predictions, say two new landmark studies with 
potentially huge consequences for AIDS vaccine design.
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Two new studies aim to answer a seem-
ingly simple question—what happens 
if two genetically identical people are 
infected with the same strain of HIV? 
In this issue, Draenert et al. (p. 529) 
study identical twins infected with the 
same strain of HIV at essentially the 
same time through needle sharing in in-
jection drug use (1). The twins were di-
agnosed with HIV soon after infection, 
allowing the investigators to track ini-
tial immune responses, viral evolution, 
and disease outcome (Fig. 1). A second 
study recently published by Yang et al. 
in the Journal of Virology followed a 
diff  erent pair of HIV+ identical twins 
infected perinatally with blood transfu-
sions from the same donor. However, 
immune responses were not monitored 
in detail until much later in the course 
of infection in this second study (2).
Strikingly, conventional markers of 
HIV disease progression were nearly 
identical within both sets of twins. The 
juvenile twins in the study by Yang 
et al. developed serious HIV complica-
tions at age 7, had similar viral loads and 
CD4+ T cell counts during several years 
of incomplete antiretroviral therapy, 
manifested late-stage disease at age 17, 
and rebounded upon initiation and ad-
herence to a diff  erent antiretroviral reg-
imen (2). In the Draenert et al. study, 
viral loads and CD4+ T cell counts 
were also very similar during 3 years of 
observation, including a precipitous 
CD4+ T cell decline  30 months after 
infection. This study was terminated 
  after 3 years when one of the twins died 
of a drug overdose (1).
Surprisingly similar CTL and antibody 
responses immediately after infection
Are the similar outcomes caused by 
identical immune responses in both 
pairs of twins? Here the picture is less 
clear, although many details of immune 
responses in the pairs of twins are very 
similar. Both groups focused their at-
tention primarily on CD8+ T lympho-
cyte (cytotoxic T lymphocyte; CTL) 
responses. 6 months after infection, 15 
of the 16 CTL epitopes recognized by 
the twins in the Draenert et al. study 
were identical (1). By 34 months, mod-
est diff   erences in the CTL responses 
emerged, though the majority of re-
sponses were still shared between both 
twins. The two twins in the Yang et al. 
study shared three CTL responses (2). 
One of the twins only mounted these 
shared responses, whereas the other 
recognized six additional epitopes. Un-
like the twins in the Draenert et al. 
study, these twins were both treated 
with antiretrovirals that suppressed HIV 
replication. It is possible that CTL re-
sponses waned in the absence of vigor-
ous HIV replication, dampening shared 
responses that may have been present 
earlier during infection. Yang et al. took 
the analysis of shared responses one step 
further than Draenert et al., discovering 
that the TCRs used by CTL against the 
same epitope were markedly diff  erent 
between the twins. This fi  nding paral-
lels the recent observation that struc-
turally diverse TCRs with distinct Vβ 
usage and high amino diversity com-
prise the CTL directed against an im-
munodominant epitope in the HIV Nef 
protein (3).
Draenert et al. also found essentially 
identical neutralizing antibody responses 
in both twins (1). Recent longitudinal 
studies of early HIV infection have 
shown that strain-specifi  c  neutralizing 
antibodies are elicited in response to the 
virus (4, 5). When these antibodies reach 
a critical threshold (a matter of weeks), a 
resistant virus emerges. Eventually, a 
neutralizing antibody response to this 
virus develops and a new resistant virus 
emerges. Apparently, the virus always 
stays one step ahead of the evolving 
neutralizing antibody response. Despite 
the continual diversifi  cation of antibody 
responses and virus as infection pro-
gresses, serum antibodies from each twin 
“stayed in step” with the virus from the 
other twin, suggesting that evolution of 
the viral envelope was synchronized in 
the two twins. This view was confi  rmed 
in general terms by sequencing of the 
gene that encodes the virus envelope.
A strength of the Draenert cohort 
(1) is its inclusion of a brother that 
shared a single HLA class I haplotype 
with his twin siblings. This brother 
shared needles with the twins and was 
infected with HIV about a year after 
the twins had become infected. The 
  authors investigated a panel of CTL 
responses restricted by the allele 
HLA-B*4001, as this allele was shared 
among all three siblings. All mounted 
an immunodominant response against 
an identical epitope in the HIV Pol 
protein, but the magnitude and ontog-
eny of other responses restricted by 
HLA-B*4001 diff   ered. This fi  nding 
suggests that the magnitude and breadth 
of the HIV-  specifi  c CTL response re-
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profoundly infl  uenced by the presence 
or absence of other HLA alleles.
CTL divergence later in infection 
and the importance of escapology
A puzzle that remains unanswered is 
why the twins’ highly concordant CTL 
responses early on ultimately became 
less uniform as the infection progressed. 
HIV sequence evolution may drive this 
diversifi  cation. In the twins studied by 
Draenert et al. (1), four CTL responses 
weakened in both brothers as the infec-
tion progressed. At the same time, mu-
tations consistent with immune escape 
arose in three of the epitopes recog-
nized by these CTL. Moreover, four 
CTL responses persisted in one twin 
and declined in the other. The reduced 
recognition of all four epitopes was ac-
companied by viral sequence changes 
that varied between the twins.
HIV mutation is a stochastic process 
and, therefore, CTL escape cannot be 
predicted absolutely. Certainly, some 
CTL responses consistently select for 
escape variants rapidly (6), but others 
do not (7). And for each epitope the 
pattern of escape mutations is limited 
but rarely completely uniform (8). Sto-
chasticity in the timing and pattern of 
CTL escape may be powering a desta-
bilizing “variability engine.” Once im-
mune escape mutants begin to accrue, 
the antigenic composition of the virus 
changes, fundamentally altering the im-
mune response. Recent studies show 
that new CTL responses emerge against 
escape mutants (9, 10), whereas CTL 
raised against wild-type epitope se-
quences often retain partial activity 
against variant epitope sequences. The 
adaptation of the immune response to 
immune escape mutants may promote 
further viral diversifi  cation, essentially 
creating a positive feedback loop that 
intimately tailors HIV to each host’s 
immune response. Data from the paper 
by Yang et al. (2) supports this hypo-
thesis: by 17 years after infection, all but 
one epitope sequence diff  ered between 
the twins, even in the subset of epitopes 
that were recognized by both.
Despite the diversifi  cation of CD8+ 
T cell responses and sequence evolution 
after long-term infection and escape, 
markers of disease progression remained 
consistent. This could imply that CD8+ 
T cell responses are a relatively minor 
determinant of long-term HIV control 
and that the questions aforementioned 
are largely academic. Alternatively, the 
long-term prognosis of infection may 
be largely dictated by immunological 
and virological events that occur early 
during infection when immune responses 
and primary escape mutations are 
  virtually identical.
Implications for vaccine design: 
immunogens that retaliate fi  rst
How do these fi   ndings inform HIV 
vaccine development? The enormous 
sequence heterogeneity of HIV is of-
ten cited as a chief stumbling block to 
the development of a vaccine. To put 
this diversity in context, the global se-
quence diversity of infl  uenza, another 
variable RNA virus, during a pandemic 
is lower than the diversity of viruses ob-
served within a single HIV-infected in-
dividual (11). Developing a vaccine to 
cope with this enormous diversity is a 
Herculean challenge, though the results 
of Draenert et al. (1) and Yang et al. (2) 
suggest that HIV variability may be a 
more manageable challenge than previ-
ously thought. Their fi  ndings show that 
it is the dominant sequences in each 
host that dictate the immune responses 
raised against the virus, and immune 
selection that consistently drives the 
turnover of the dominant viral popula-
tion. Global HIV sequence heterogene-
ity (defi  ned by sequencing the virus in 
a cross section of the infected popula-
tion), therefore, may be little more than 
the aggregate eff  ect of immune selection
Figure 1.  Initial sharing of HIV-specifi  c CTL responses is largely lost by late-stage 
infection. Two sets of identical twins were infected with identical stocks of HIV. The twins followed 
by Draenert et al. and described in this issue of JEM (1) (Twins 1 and 2) were infected by intravenous 
drug use and were followed during the fi  rst 3 years of infection (A). Yang et al. (2) studied twins 3 
and 4, who were infected by blood transfusion, during late-stage infection (B). CTL responses shared 
between both twins in each pair are shown as gray cells. CTL responses mounted only by one twin in 
each pair are colored pink.COMMENTARY
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during millions of HIV person-years. If 
true, this raises the hope that the muta-
tional history of HIV can be deciphered 
and used to understand the interplay of 
immune responses and viral sequence 
evolution in diff  erent populations and 
over time.
Importantly, the papers by Draenert 
et al. (1) and Yang et al. (2) suggest that 
there is a window in HIV infection, al-
beit a relatively short one, during which 
immune responses, viral evolution, and 
disease progression are relatively repro-
ducible. The reproducibility observed in 
the paper by Draenert et al. raises the ex-
citing possibility that the early events of 
HIV infection could, in fact, be predicted 
from preexisting genetic data. Such an 
analysis may highlight key indicators for 
disease progression and guide vaccine 
design. In particular, it may be possible 
to “corner” the virus with immunogens 
that are designed to control the virus not 
only in its current guise but in guises 
that it is predicted to adopt. Generating 
predictions would likely require orders 
of magnitude more data than is cur-
rently available, as well as an enormous 
amount of raw supercomputing power, 
but could prove well worth the eff  ort. 
The stochasticity imparted by variable 
CTL escape and TCR utilization will 
likely limit the value of such models to 
predict the entire natural history of HIV 
infection. Nonetheless, these papers alter 
the landscape of HIV research, provid-
ing some order to a disease that is largely 
known for its variability.
REFERENCES
  1. Draenert, R., T.M. Allen, Y. Liu, T. 
Wrin, C. Chappey, C. Verrill, G. Sirera, 
R.L. Eldridge, M.P. Lahaie, L. Ruiz, B. 
Clotet, C.J. Petropoulos, B.D. Walker, 
and J. Martinez-Picado. Constraints on 
HIV-1 evolution and immunodominance 
revealed in monozygotic adult twins in-
fected with the same virus. J. Exp. Med. 
203:529–539.
 2. Yang, O.O., J. Church, C.M. Kitchen, R. 
Kilpatrick, A. Ali, Y. Geng, M.S. Killian, 
R.L. Sabado, H. Ng, J. Suen, et al. 2005. 
Genetic and stochastic infl  uences on the in-
teraction of human immunodefi  ciency virus 
type 1 and cytotoxic T lymphocytes in iden-
tical twins. J. Virol. 79:15368–15375.
  3.  Meyer-Olson, D., K.W. Brady, M.T. 
Bartman, K.M. O’Sullivan, B.C. Simons, 
J.A. Conrad, C.B. Duncan, S. Lorey, 
A. Siddique, R.A. Draenert, et al. 2005. 
Fluctuations of functionally distinct CD8+ 
T cell clonotypes demonstrate fl  exibility of 
the HIV-specifi   c TCR repertoire. Blood. 
10.1182/blood-2005-04-1636. 
 4. Richman, D.D., T. Wrin, S.J. Little, and 
C.J. Petropoulos. 2003. Rapid evolution of 
the neutralizing antibody response to HIV 
type 1 infection. Proc. Natl. Acad. Sci. USA. 
100:4144–4149.
  5.  Wei, X., J.M. Decker, S. Wang, H. Hui, J.C. 
Kappes, X. Wu, J.F. Salazar-Gonzalez, M.G. 
Salazar, J.M. Kilby, M.S. Saag, et al. 2003. 
Antibody neutralization and escape by HIV- 1. 
Nature. 422:307–312.
  6.  Price, D.A., P.J. Goulder, P. Klenerman, A.K. 
Sewell, P.J. Easterbrook, M. Troop, C.R. 
Bangham, and R.E. Phillips. 1997. Positive 
selection of HIV-1 cytotoxic T lymphocyte 
escape variants during primary infection. Proc. 
Natl. Acad. Sci. USA. 94:1890–1895.
 7. Koibuchi, T., T.M. Allen, M. Lichterfeld, 
S.K. Mui, K.M. O’Sullivan, A. Trocha, S.A. 
Kalams, R.P. Johnson, and B.D. Walker. 
2005. Limited sequence evolution within 
persistently targeted CD8 epitopes in chronic 
human immunodefi  ciency virus type 1 infec-
tion. J. Virol. 79:8171–8181.
 8. Allen, T.M., M. Altfeld, S.C. Geer, E.T. 
Kalife, C. Moore, K.M. O’sullivan, I. Desouza, 
M.E. Feeney, R.L. Eldridge, E.L. Maier, 
et al. 2005. Selective escape from CD8+ 
T-cell responses represents a major driving 
force of human immunodefi  ciency virus type 
1 (HIV-1) sequence diversity and reveals 
constraints on HIV-1 evolution. J. Virol. 
79:13239-13249. 
 9. Allen, T.M., X.G. Yu, E.T. Kalife, L.L. 
Reyor, M. Lichterfeld, M. John, M. Cheng, 
R.L. Allgaier, S. Mui, N. Frahm, et al. 2005. 
De novo generation of escape variant-specifi  c 
CD8+ T-cell responses following cytotoxic 
T-lymphocyte escape in chronic human 
  immunodefi  ciency virus type 1 infection. J. 
Virol. 79:12952–12960.
10. Feeney, M.E., Y. Tang, K. Pfaff  erott, K.A. 
Roosevelt, R. Draenert, A. Trocha, X.G. 
Yu, C. Verrill, T. Allen, C. Moore, et al. 
2005. HIV-1 viral escape in infancy followed 
by emergence of a variant-specifi  c CTL re-
sponse. J. Immunol. 174:7524–7530.
11. Korber, B., B. Gaschen, K. Yusim, R. 
Thakallapally, C. Kesmir, and V. Detours. 
2001. Evolutionary and immunological im-
plications of contemporary HIV-1 variation. 
Br. Med. Bull. 58:19–42.